Sodium Nitrite — Competitive Intelligence Brief

Sodium Nitrite (SODIUM NITRITE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: sodium nitrite. Area: Metabolic.

marketed sodium nitrite Carbonic anhydrase 1 Metabolic Small molecule

Target snapshot

Sodium Nitrite (SODIUM NITRITE) — Hope Pharms. Sodium nitrite works by converting hemoglobin to methemoglobin, which binds to cyanide and prevents it from interfering with cellular respiration.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Sodium Nitrite TARGET	SODIUM NITRITE	Hope Pharms	marketed	sodium nitrite	Carbonic anhydrase 1	2011-01-01
Syprine	TRIENTINE	Bausch Health	marketed	Copper Chelator	Carbonic anhydrase 14	1985-01-01
Plasma-Lyte A In Plastic Container	Sodium Acetate	Pfizer	marketed	sodium acetate	Carbonic anhydrase 1, Carbonic anhydrase	1983-01-01
Ethamide	ETHOXZOLAMIDE	Pfizer	marketed	ethoxzolamide	Carbonic anhydrase 1, Carbonic anhydrase 12, Carbonic anhydrase 13	1982-01-01
Sulfamylon	MAFENIDE	Rising	marketed	Methylated Sulfonamide Antibacterial	Carbonic anhydrase 12	1969-01-01
Avc	SULFANILAMIDE	Pharmobedient	marketed	sulfanilamide	Carbonic anhydrase 13	1965-01-01
Dihydrex	BENZTHIAZIDE	Ah Robins Inc	marketed	benzthiazide	Calcium-activated potassium channel subunit alpha-1, Carbonic anhydrase 1, Carbonic anhydrase 2	1960-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (sodium nitrite class)

1. Hope Pharms · 1 drug in this class